The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study by Santarsieri, Anna, MD, Mitchell, Emily, PhD, Pham, My H, MPhil, Sanghvi, Rashesh, MSc, Jablonski, Janina, MSc, Lee-Six, Henry, PhD, Sturgess, Katherine, PhD, Brice, Pauline, PhD, Menne, Tobias F, PhD, Osborne, Wendy, MD, Creasey, Thomas, PhD, Ardeshna, Kirit M, MD, Baxter, Joanna, PhD, Behan, Sarah, DipHE, Bhuller, Kaljit, MD, Booth, Stephen, MD, Chavda, Nikesh D, MD, Collins, Graham P, Prof, Culligan, Dominic J, MD, Cwynarski, Kate, PhD, Davies, Andrew, Prof, Downing, Abigail, MD, Dutton, David, MD, Furtado, Michelle, PhD, Gallop-Evans, Eve, PhD, Hodson, Andrew, MD, Hopkins, David, MD, Hsu, Hannah, MD, Iyengar, Sunil, PhD, Jones, Stephen G, MD, Karanth, Mamatha, MD, Linton, Kim M, PhD, Lomas, Oliver C, PhD, Martinez-Calle, Nicolas, PhD, Mathur, Abhinav, MD, McKay, Pamela, MD, Nagumantry, Sateesh K, MD, Phillips, Elizabeth H, MD, Phillips, Neil, MD, Rudge, John F, Prof, Shah, Nimish K, MD, Stafford, Gwyneth, BSc, Sternberg, Alex, MD, Trickey, Rachel, MD, Uttenthal, Benjamin J, PhD, Wetherall, Natasha, MD, Zhang, Xiao-Yin, MD, McMillan, Andrew K, PhD, Coleman, Nicholas, Prof, Stratton, Michael R, Prof, Laurenti, Elisa, PhD, Borchmann, Peter, Prof, Borchmann, Sven, PhD, Campbell, Peter J, PhD, Rahbari, Raheleh, PhD, Follows, George A, Prof

Get full text

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial by Trotman, Judith, Prof, Barrington, Sally F, Prof, Belada, David, MD, Meignan, Michel, Prof, MacEwan, Robert, MD, Owen, Carolyn, MD, Ptáčník, Václav, MD, Rosta, András, MD, Fingerle-Rowson, Günter R, MD, Zhu, Jiawen, PhD, Nielsen, Tina, MD, Sahin, Deniz, BSc, Hiddemann, Wolfgang, Prof, Marcus, Robert E, MD, Davies, Andrew, MD

Get full text